By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Helicos BioSciences' 2010 revenues rose 47 percent year over year, the company disclosed in a document filed with the US Securities and Exchange Commission late on Thursday.

The Cambridge, Mass.-based firm did not break out revenues for its fourth quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.